Sustained-release pregabalin with methylcobalamin in neuropathic pain: an Indian real-life experience
Yasmin U Dongre, Onkar C Swami Unichem Laboratories Ltd, Unichem Bhavan, Mumbai, India Introduction: Neuropathic pain is intense in nature and difficult to manage. Thus, the primary goal is maximum relief from pain. The aim of this study was to assess the efficacy and safety of a fixed-dose combinat...
Main Authors: | Dongre YU, Swami OC |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2013-05-01
|
Series: | International Journal of General Medicine |
Online Access: | http://www.dovepress.com/sustained-release-pregabalin-with-methylcobalamin-in-neuropathic-pain--a13195 |
Similar Items
-
Randomized study to compare the effect of pregabalin with fixed-drug combination of pregabalin and methylcobalamin in the patients of postherpetic neuralgia
by: Asmita Jha, et al.
Published: (2018-01-01) -
A clinical study to compare the efficacy and safety of pregabalin sustained release formulation with pregabalin immediate release formulation in patients of diabetic peripheral neuropathic pain
by: A Srivastava, et al.
Published: (2012-01-01) -
Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study
by: D Vasudevan, et al.
Published: (2014-01-01) -
Efficacy and safety of methylcobalamin, alpha lipoic acid and pregabalin combination versus pregabalin monotherapy in improving pain and nerve conduction velocity in type 2 diabetes associated impaired peripheral neuropathic condition. [MAINTAIN]: Results of a pilot study
by: D Vasudevan, et al.
Published: (2014-01-01) -
Duloxetine and pregabalin in neuropathic pain of lung cancer patients
by: Şule Karabulut Gül, et al.
Published: (2020-03-01)